Literature DB >> 33283153

The impact of COVID-19 pandemic on ophthalmology services: are we ready for the aftermath?

Darren Shu Jeng Ting1, Rashmi Deshmukh2, Dalia G Said3, Harminder S Dua1.   

Abstract

Entities:  

Year:  2020        PMID: 33283153      PMCID: PMC7685677          DOI: 10.1177/2515841420964099

Source DB:  PubMed          Journal:  Ther Adv Ophthalmol        ISSN: 2515-8414


× No keyword cloud information.
Editor, Since the World Health Organization’s declaration of the pandemic status of Coronavirus Disease 2019 (or COVID-19) on 11 March 2020, many countries across the world, including the United Kingdom, had imposed nationwide lockdown. Routine healthcare services were cancelled, and patients were advised to avoid hospital visits, unless critically necessary, to minimize the risk of COVID-19 transmission, leading to significant disruption to the provision of healthcare service and patient care. Ophthalmology represents one of the busiest and most heavily outpatient-oriented specialties, with ~7.5 million outpatient appointments and >500,000 surgical procedures being provided in the United Kingdom each year.[1] The recent pandemic lockdown had resulted in cancellation of thousands of ophthalmic clinical visits and surgeries, which could potentially lead to permanent and significant harm to patient’s vision.[2] In addition, our recent survey among the general public with eye diseases highlighted a significant negative psychosocial impact of lockdown on individuals with visual impairment, with around 50% of them expressing fear of further sight loss due to delayed review or treatment.[3] Therefore, it is important that efficient measures are implemented during and after the COVID-19 pandemic to avoid any irreversible sight loss among these patients. However, effective reformation, adaptation, and delivery of the ophthalmic service require a full grasp of the impact of pandemic lockdown, for which the data are limited in the literature. With this in mind, we recently conducted a retrospective analysis of the changing trend in capacity and workload of the ophthalmology service in Queen’s Medical Centre, Nottingham, United Kingdom, between 01 June 2019 and 31 June 2020. All data, including the number of clinical and surgical activities, and cases that breached the 18-week referral-to-treatment (RTT) waiting time (https://www.england.nhs.uk/rtt/), were collected from the hospital-wide database and were analysed. The 18-week RTT is a national initiative implemented by the UK government to ensure that all patients were reviewed and treated in hospitals within 18 weeks of the referral initiated by their primary care physicians. It is often used as an indicator of the backlog of clinical and surgical work. For this study, the date, 18 March 2020, was used as the cut-off point to analyse the impact of COVID-19 lockdown. This study was approved by the Nottingham University Hospital NHS Trust as a service evaluation study (Ref: 20-351 C). When comparing June 2019 (pre-COVID-19) and June 2020 (during COVID-19 pandemic), we observed a substantial 63% and 67% reduction in the outpatient and surgical activities, respectively. In addition, there was a significant ~1800% increase in the number of virtual- or tele-consultation visits (p < 0.0001; Figure 1), highlighting the real-world utility and patient receptivity of telemedicine during the COVID-19 period. From 18 March 2020 to 01 July 2020 (a 15-week period), there was a significant increase in the 18-week RTT breaches/waiting list in outpatient review (by 75%) and surgeries (by 471%; Figure 2). Cataract surgery (53%) formed the majority of the surgical backlog, followed by YAG laser procedures (24%) and oculoplastic surgeries (8%; Table 1).
Figure 1.

A direct month-to-month comparison of clinical and surgical activities in ophthalmology before COVID-19 (June 2019) and during COVID-19 period (June 2020).

Figure 2.

The number of ophthalmology cases that breached the 18-week referral-to-treatment waiting time for outpatient review (a) and surgery (b). The vertical red dotted line indicated the time point (18 March 2020) where ophthalmic routine services were cancelled.

Table 1.

Summary of the surgical backlog that had breached the 18-week referral-to-treatment waiting time.

Types of surgeryTotal N = 2017;n (%)
Cataract surgery1078 (53.4)
YAG laser procedures491 (24.3)
Oculoplastic surgeries165 (8.2)
Squint surgeries81 (4.0)
Orbital and lacrimal surgeries53 (2.6)
Corneal and conjunctival surgeries42 (2.1)
Vitreoretinal surgeries41 (2.0)
Glaucoma surgeries28 (1.4)
Others38 (1.9)
A direct month-to-month comparison of clinical and surgical activities in ophthalmology before COVID-19 (June 2019) and during COVID-19 period (June 2020). The number of ophthalmology cases that breached the 18-week referral-to-treatment waiting time for outpatient review (a) and surgery (b). The vertical red dotted line indicated the time point (18 March 2020) where ophthalmic routine services were cancelled. Summary of the surgical backlog that had breached the 18-week referral-to-treatment waiting time. COVID-19 has paralysed the healthcare system globally and understanding of the true impact helps strategise service delivery planning and workforce/resource allocation during the post-COVID-19 period, ultimately minimizing any harm to patients’ vision and quality of life. To our best knowledge, this represents the first study evaluating the true magnitude of the impact of COVID-19 on the ophthalmology services in the United Kingdom. Babu and colleagues[4] similarly reported a significant impact of COVID-19 pandemic on the ophthalmology service in India, with clinical and surgical services being reduced by >95%. Interestingly, only a low (~2%) utility of tele-consultation was observed, which was in contrast to our findings. The disparity is likely attributed to the cultural difference, level of education, and patient receptivity of telemedicine. Cataract surgery is by far the most commonly performed procedure in ophthalmology. In view of its elective nature, cancellation of routine ophthalmic service has resulted in a significant increase in the cataract surgery backlog during the COVID pandemic, as shown in our study. Lin and colleagues[5] have recently highlighted several valuable strategies to cope with the backlog of cataract surgery, including the adoption of telemedicine, modification of face-to-face encounters, better theatre organisation, and immediate sequential bilateral cataract surgery, among others. With the mounting pressure on ophthalmic service compounded by the recent pandemic, adoption of digitalized healthcare systems using telemedicine and/or artificial intelligence-assisted platforms is urgently required to tackle this unprecedented impact on healthcare systems and patients.[6,7] However, it is noteworthy to mention that any plan to maximize throughput of clinical visits and ophthalmic elective surgeries, particularly cataract surgery, needs to be carried out in the context of the entire service and prioritization of emergency services.
  6 in total

1.  Surveillance of sight loss due to delay in ophthalmic treatment or review: frequency, cause and outcome.

Authors:  B Foot; C MacEwen
Journal:  Eye (Lond)       Date:  2017-01-27       Impact factor: 3.775

2.  Artificial intelligence-assisted telemedicine platform for cataract screening and management: a potential model of care for global eye health.

Authors:  Darren Shu Jeng Ting; Marcus Ang; Jodhbir S Mehta; Daniel Shu Wei Ting
Journal:  Br J Ophthalmol       Date:  2019-09-02       Impact factor: 4.638

Review 3.  Cataract service redesign in the post-COVID-19 era.

Authors:  Pei-Fen Lin; Hasan Naveed; Maria Eleftheriadou; Robert Purbrick; Mehran Zarei Ghanavati; Christopher Liu
Journal:  Br J Ophthalmol       Date:  2020-07-23       Impact factor: 4.638

Review 4.  Artificial intelligence for anterior segment diseases: Emerging applications in ophthalmology.

Authors:  Darren Shu Jeng Ting; Valencia Hx Foo; Lily Wei Yun Yang; Josh Tjunrong Sia; Marcus Ang; Haotian Lin; James Chodosh; Jodhbir S Mehta; Daniel Shu Wei Ting
Journal:  Br J Ophthalmol       Date:  2020-06-12       Impact factor: 4.638

5.  To evaluate the effect of COVID-19 pandemic and national lockdown on patient care at a tertiary-care ophthalmology institute.

Authors:  Naresh Babu; Piyush Kohli; Chitaranjan Mishra; Sagnik Sen; Dhipak Arthur; Deepesh Chhablani; Girish Baliga; Kim Ramasamy
Journal:  Indian J Ophthalmol       Date:  2020-08       Impact factor: 1.848

6.  Psychosocial impact of COVID-19 pandemic lockdown on people living with eye diseases in the UK.

Authors:  Darren Shu Jeng Ting; Sherine Krause; Dalia G Said; Harminder S Dua
Journal:  Eye (Lond)       Date:  2020-08-10       Impact factor: 3.775

  6 in total
  12 in total

1.  Drug-Loaded Polymeric Micelles Based on Smart Biocompatible Graft Copolymers with Potential Applications for the Treatment of Glaucoma.

Authors:  Manuela-Ramona Blanaru Ozturk; Marcel Popa; Delia Mihaela Rata; Anca Niculina Cadinoiu; Frederique Parfait; Christelle Delaite; Leonard Ionut Atanase; Carmen Solcan; Oana Maria Daraba
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

2.  The Impact of the COVID-19 Pandemic and Lockdown on Macular Hole Surgery Provision and Surgical Outcomes: A Single-Centre Experience.

Authors:  Georgios D Panos; Olyvia Poyser; Humera Sarwar; Dharmalingam Kumudhan; Gavin Orr; Anwar Zaman; Craig Wilde
Journal:  J Clin Med       Date:  2022-06-26       Impact factor: 4.964

3.  The Impact of Three Waves of the COVID-19 Pandemic on the Characteristics of Primary Rhegmatogenous Retinal Detachments at a Tertiary Referral Centre.

Authors:  Diana Dmuchowska; Izabela Cwalina; Pawel Krasnicki; Joanna Konopinska; Emil Saeed; Zofia Mariak; Iwona Obuchowska
Journal:  Clin Ophthalmol       Date:  2021-08-16

4.  The current use of glaucoma virtual clinics in Europe.

Authors:  Matthew Azzopardi; Verena Prokosch-Willing; Manuele Michelessi; Antonio Maria Fea; Francesco Oddone; Karl Mercieca
Journal:  Eye (Lond)       Date:  2022-06-11       Impact factor: 4.456

5.  Comment on: The Impact of COVID-19 on Individuals Across the Spectrum of Visual Impairment.

Authors:  Darren Shu Jeng Ting; Sherine Krause; Dalia G Said; Harminder S Dua
Journal:  Am J Ophthalmol       Date:  2021-05-11       Impact factor: 5.488

Review 6.  Application of artificial intelligence in cataract management: current and future directions.

Authors:  Laura Gutierrez; Jane Sujuan Lim; Li Lian Foo; Wei Yan Ng; Michelle Yip; Gilbert Yong San Lim; Melissa Hsing Yi Wong; Allan Fong; Mohamad Rosman; Jodhbir Singth Mehta; Haotian Lin; Darren Shu Jeng Ting; Daniel Shu Wei Ting
Journal:  Eye Vis (Lond)       Date:  2022-01-07

Review 7.  Diagnostic armamentarium of infectious keratitis: A comprehensive review.

Authors:  Darren S J Ting; Bhavesh P Gopal; Rashmi Deshmukh; Gerami D Seitzman; Dalia G Said; Harminder S Dua
Journal:  Ocul Surf       Date:  2021-11-13       Impact factor: 5.033

8.  Impact of COVID-19-associated anxiety on the adherence to intravitreal injection in patients with macular diseases a year after the initial outbreak.

Authors:  Siyin Liu; Jonathan K Y Ng; Emily Haejoon Moon; Daisy Morgan; Natalie Woodhouse; Dakshita Agrawal; Laura Chan; Ramandeep Chhabra
Journal:  Ther Adv Ophthalmol       Date:  2022-01-31

9.  Implementation of a new telephone triage system in ophthalmology emergency department during COVID-19 pandemic: clinical effectiveness, safety and patient satisfaction.

Authors:  Yunzi Chen; Rehab Ismail; Muhammad R Cheema; Darren S J Ting; Ibrahim Masri
Journal:  Eye (Lond)       Date:  2021-05-25       Impact factor: 4.456

10.  All India Ophthalmological Society Financial Impact Survey on ophthalmology practice in India during COVID-19.

Authors:  Divya Agarwal; Rohit Saxena; Rajesh Sinha; Deepak Mishra; Mahipal S Sachdev; Namrata Sharma
Journal:  Indian J Ophthalmol       Date:  2021-08       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.